BCA
NTUS

Berman Capital Advisors’s Natus Medical Inc NTUS Stock Holding History

Berman Capital Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2K Buy
106
+12
+13% +$306 ﹤0.01% 1773
2021
Q2 		$2K Hold
94
– – ﹤0.01% 1667
2021
Q1 		$2K Hold
94
– – ﹤0.01% 1571
2020
Q4 		$1K Hold
94
– – ﹤0.01% 1630
2020
Q3 		$1K Buy
+94
New +$1.78K ﹤0.01% 1555

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Berman Capital Advisors's NTUS Position: Q3 2021 in Review

Berman Capital Advisors increased its Natus Medical Inc (NTUS) stake by 13% in Q3 2021, buying an estimated $306 and bringing the position to 106 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1773.

Berman Capital Advisors first reported a position in NTUS in Q3 2020 and has held it in 5 quarters since. 169 funds tracked by Wall St. Rank hold NTUS as of Q3 2021.

  • Berman Capital Advisors held 106 shares of Natus Medical Inc worth $2K as of Q3 2021.
  • Berman Capital Advisors bought 12 Natus Medical Inc shares in Q3 2021, an estimated $306.
  • Natus Medical Inc made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1773 holding.
  • Berman Capital Advisors first reported a position in Natus Medical Inc in Q3 2020 and has held it in 5 quarters since.
  • 169 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.